Already approved drug avapritinib shows promise in treating high-grade gliomas

High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, incidence of recurrence and difficulty for drugs to cross the blood-brain barrier.

Quality-of-life measurements are essential in cancer care, study says

As novel cancer treatments continually emerge, it is essential to collect data on patients’ quality of life along with how the treatment is working to

August 5, 2024

New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy

A machine learning-based heart disease prediction model (ML-HDPM) that uses various combinations of information and numerous recognized categorization methods.

April 5, 2024

Huma Secures $80M, Launches ‘Shopify Style’ GenAI Platform

What You Should Know: – Huma Therapeutics Limited, a leading global healthcare AI company, today announced the closing of its Series D funding round, securing

July 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.